A stronger result than I was expecting TBH. Locking for revenue to be generated from Mobvoi and Pulse next quarter to slow the drain on cash, but I think the sleeper is our base Atcor business. Craig keeps saying that the ATCOR division will move to profit in 2022, I think we may be underestimating the growth potential … the latest kidney health paper and the correlation to CBP published on the ATCOR website gives an insight that they are pushing medical rebates and application of our technology well beyond the cardiovascular system.
Anyone intending on going to the AGM next Thursday … I’m thinking of going … you never know, might get a glimpse of Conneqt Pulse.
Add to My Watchlist
What is My Watchlist?
